Publication | Closed Access

731 Interim results of a multiple ascending dose study of R1626, a novel nucleoside analog targeting hcv polymerase in chronic HCV patients

HepatologyChronic Hcv PatientsViral HepatitisPharmacologyAntiviral Drug DevelopmentHepatitisVirologyAntiviral TherapyInterim ResultsAntiviral DrugMedicineAntiviral CompoundHcv Polymerase